Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification.
Animals
Cell Line, Tumor
Glucose Intolerance
/ genetics
Homeostasis
Insulin
/ metabolism
Insulin-Secreting Cells
/ metabolism
Insulinoma
/ genetics
Iron
/ metabolism
Iron Regulatory Protein 2
/ genetics
Iron-Sulfur Proteins
/ metabolism
Mice, Inbred C57BL
Mice, Knockout
Pancreatic Neoplasms
/ genetics
Proinsulin
/ genetics
RNA, Transfer, Lys
/ genetics
Rats
Unfolded Protein Response
/ genetics
tRNA Methyltransferases
/ genetics
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
15 01 2020
15 01 2020
Historique:
received:
03
12
2018
accepted:
06
12
2019
entrez:
17
1
2020
pubmed:
17
1
2020
medline:
14
4
2020
Statut:
epublish
Résumé
Regulation of cellular iron homeostasis is crucial as both iron excess and deficiency cause hematological and neurodegenerative diseases. Here we show that mice lacking iron-regulatory protein 2 (Irp2), a regulator of cellular iron homeostasis, develop diabetes. Irp2 post-transcriptionally regulates the iron-uptake protein transferrin receptor 1 (TfR1) and the iron-storage protein ferritin, and dysregulation of these proteins due to Irp2 loss causes functional iron deficiency in β cells. This impairs Fe-S cluster biosynthesis, reducing the function of Cdkal1, an Fe-S cluster enzyme that catalyzes methylthiolation of t
Identifiants
pubmed: 31941883
doi: 10.1038/s41467-019-14004-5
pii: 10.1038/s41467-019-14004-5
pmc: PMC6962211
doi:
Substances chimiques
Insulin
0
Iron-Sulfur Proteins
0
RNA, Transfer, Lys
0
Proinsulin
9035-68-1
Iron
E1UOL152H7
tRNA Methyltransferases
EC 2.1.1.-
CDKAL1 protein, mouse
EC 2.8.4.5
Ireb2 protein, mouse
EC 4.2.1.3
Iron Regulatory Protein 2
EC 4.2.1.3
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
296Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM045201
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107712
Pays : United States
Organisme : NIDDK NIH HHS
ID : U54 DK110858
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007115
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES002109
Pays : United States
Références
Rajpathak, S. N. et al. The role of iron in type 2 diabetes in humans. Biochim. Biophys. Acta 1790, 671–681 (2009).
pubmed: 18501198
doi: 10.1016/j.bbagen.2008.04.005
pmcid: 18501198
Simcox, J. A. & McClain, D. A. Iron and diabetes risk. Cell Metab. 17, 329–341 (2013).
pubmed: 23473030
pmcid: 3648340
doi: 10.1016/j.cmet.2013.02.007
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B. & Mandrup-Poulsen, T. Iron regulation of pancreatic beta-cell functions and oxidative stress. Annu. Rev. Nutr. 36, 241–273 (2016).
pubmed: 27146016
doi: 10.1146/annurev-nutr-071715-050939
pmcid: 27146016
Hansen, J. B. et al. Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic beta cell fate in response to cytokines. Cell Metab. 16, 449–461 (2012).
pubmed: 23000401
doi: 10.1016/j.cmet.2012.09.001
pmcid: 23000401
Cooksey, R. C. et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145, 5305–5312 (2004).
pubmed: 15308612
doi: 10.1210/en.2004-0392
pmcid: 15308612
Ristow, M. et al. Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest. 112, 527–534 (2003).
pubmed: 12925693
pmcid: 171391
doi: 10.1172/JCI18107
Braymer, J. J. & Lill, R. Iron-sulfur cluster biogenesis and trafficking in mitochondria. J. Biol. Chem. 292, 12754–12763 (2017).
pubmed: 28615445
pmcid: 5546016
doi: 10.1074/jbc.R117.787101
Netz, D. J., Mascarenhas, J., Stehling, O., Pierik, A. J. & Lill, R. Maturation of cytosolic and nuclear iron-sulfur proteins. Trends Cell Biol. 24, 303–312 (2014).
pubmed: 24314740
doi: 10.1016/j.tcb.2013.11.005
pmcid: 24314740
Rouault, T. A. Mammalian iron-sulphur proteins: novel insights into biogenesis and function. Nat. Rev. Mol. Cell Biol. 16, 45–55 (2015).
pubmed: 25425402
doi: 10.1038/nrm3909
pmcid: 25425402
Rouault, T. A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2, 406–414 (2006).
pubmed: 16850017
doi: 10.1038/nchembio807
pmcid: 16850017
Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24–38 (2010).
pubmed: 20603012
doi: 10.1016/j.cell.2010.06.028
pmcid: 20603012
Anderson, C. P., Shen, M., Eisenstein, R. S. & Leibold, E. A. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta 1823, 1468–1483 (2012).
pubmed: 22610083
pmcid: 3675657
doi: 10.1016/j.bbamcr.2012.05.010
Vashisht, A. A. et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 326, 718–721 (2009).
pubmed: 19762596
pmcid: 2929180
doi: 10.1126/science.1176333
Salahudeen, A. A. et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326, 722–726 (2009).
pubmed: 19762597
pmcid: 3582197
doi: 10.1126/science.1176326
Cooperman, S. S. et al. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood 106, 1084–1091 (2005).
pubmed: 15831703
pmcid: 1895161
doi: 10.1182/blood-2004-12-4703
Galy, B. et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 106, 2580–2589 (2005).
pubmed: 15956281
doi: 10.1182/blood-2005-04-1365
pmcid: 15956281
Zumbrennen-Bullough, K. B. et al. Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments. PLoS ONE 9, e98072 (2014).
pubmed: 24896637
pmcid: 4045679
doi: 10.1371/journal.pone.0098072
Jeong, S. Y. et al. Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS ONE 6, e25404 (2011).
pubmed: 22003390
pmcid: 3189198
doi: 10.1371/journal.pone.0025404
Arragain, S. et al. Identification of eukaryotic and prokaryotic methylthiotransferase for biosynthesis of 2-methylthio-N6-threonylcarbamoyladenosine in tRNA. J. Biol. Chem. 285, 28425–28433 (2010).
pubmed: 20584901
pmcid: 2937867
doi: 10.1074/jbc.M110.106831
Wei, F. Y. et al. Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice. J. Clin. Invest. 121, 3598–3608 (2011).
pubmed: 21841312
pmcid: 3163968
doi: 10.1172/JCI58056
Steinthorsdottir, V. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770–775 (2007).
pubmed: 17460697
doi: 10.1038/ng2043
pmcid: 17460697
Diabetes Genetics Initiative of Broad Institute of, H. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331–1336 (2007).
doi: 10.1126/science.1142358
Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341–1345 (2007).
pubmed: 17463248
pmcid: 3214617
doi: 10.1126/science.1142382
Zeggini, E. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336–1341 (2007).
pubmed: 17463249
pmcid: 3772310
doi: 10.1126/science.1142364
Galy, B. et al. Iron regulatory proteins secure mitochondrial iron sufficiency and function. Cell Metab. 12, 194–201 (2010).
pubmed: 20674864
doi: 10.1016/j.cmet.2010.06.007
pmcid: 20674864
Arunagiri, A. et al. Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes. Ann. N. Y Acad. Sci. 1418, 5–19 (2018).
pubmed: 29377149
pmcid: 5934315
doi: 10.1111/nyas.13531
Back, S. H. & Kaufman, R. J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 81, 767–793 (2012).
pubmed: 22443930
pmcid: 3684428
doi: 10.1146/annurev-biochem-072909-095555
Papa, F. R. Endoplasmic reticulum stress, pancreatic beta-cell degeneration, and diabetes. Cold Spring Harb. Perspect. Med. 2, a007666 (2012).
pubmed: 22951443
pmcid: 3426819
doi: 10.1101/cshperspect.a007666
Brambillasca, S. et al. CDK5 regulatory subunit-associated protein 1-like 1 (CDKAL1) is a tail- anchored protein in the endoplasmic reticulum (ER) of insulinoma cells. J. Biol. Chem. 287, 41808–41819 (2012).
pubmed: 23048041
pmcid: 3516729
doi: 10.1074/jbc.M112.376558
Lill, R., Srinivasan, V. & Muhlenhoff, U. The role of mitochondria in cytosolic-nuclear iron-sulfur protein biogenesis and in cellular iron regulation. Curr. Opin. Microbiol. 22C, 111–119 (2014).
doi: 10.1016/j.mib.2014.09.015
Koshimizu, H., Kim, T., Cawley, N. X. & Loh, Y. P. Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul. Pept. 160, 153–159 (2010).
pubmed: 20006653
doi: 10.1016/j.regpep.2009.12.007
pmcid: 20006653
Groenewoud, M. J. et al. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51, 1659–1663 (2008).
pubmed: 18618095
doi: 10.1007/s00125-008-1083-z
pmcid: 18618095
Stancakova, A. et al. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J. Clin. Endocrinol. Metab. 93, 1924–1930 (2008).
pubmed: 18285412
doi: 10.1210/jc.2007-2218
pmcid: 18285412
Kirchhoff, K. et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51, 597–601 (2008).
pubmed: 18264689
doi: 10.1007/s00125-008-0926-y
pmcid: 18264689
Pascoe, L. et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 56, 3101–3104 (2007).
pubmed: 17804762
doi: 10.2337/db07-0634
pmcid: 17804762
Oslowski, C. M. & Urano, F. The binary switch that controls the life and death decisions of ER stressed beta cells. Curr. Opin. Cell Biol. 23, 207–215 (2011).
pubmed: 21168319
doi: 10.1016/j.ceb.2010.11.005
Muoio, D. M. & Newgard, C. B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 193–205 (2008).
pubmed: 18200017
doi: 10.1038/nrm2327
Ohara-Imaizumi, M. et al. Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis. PLoS ONE 5, e15553 (2010).
pubmed: 21151568
pmcid: 3000340
doi: 10.1371/journal.pone.0015553
Gabrielsen, J. S. et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest. 122, 3529–3540 (2012).
pubmed: 22996660
pmcid: 3461897
doi: 10.1172/JCI44421
Gao, Y. et al. Adipocyte iron regulates leptin and food intake. J. Clin. Invest. 125, 3681–3691 (2015).
pubmed: 26301810
pmcid: 4588289
doi: 10.1172/JCI81860
Hussain, M. A., Akalestou, E. & Song, W. J. Inter-organ communication and regulation of beta cell function. Diabetologia 59, 659–667 (2016).
pubmed: 26791990
pmcid: 4801104
doi: 10.1007/s00125-015-3862-7
Cantley, J. The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis. Mamm. Genome 25, 442–454 (2014).
pubmed: 25146550
doi: 10.1007/s00335-014-9538-7
pmcid: 25146550
Tao, C., Sifuentes, A. & Holland, W. L. Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic beta cells and adipocytes. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 43–58 (2014).
pubmed: 24417945
doi: 10.1016/j.beem.2013.11.003
pmcid: 24417945
Take, K. et al. CDK5 regulatory subunit-associated protein 1-like 1 negatively regulates adipocyte differentiation through activation of Wnt signaling pathway. Sci. Rep. 7, 7326 (2017).
pubmed: 28779110
pmcid: 5544666
doi: 10.1038/s41598-017-06469-5
Palmer, C. J. et al. Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue. Mol. Metab. 6, 1212–1225 (2017).
pubmed: 29031721
pmcid: 5641635
doi: 10.1016/j.molmet.2017.07.013
Takesue, Y. et al. Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas. Endocr. J. 66, 807–816 (2019).
pubmed: 31189758
doi: 10.1507/endocrj.EJ18-0536
pmcid: 31189758
Zhou, Y. et al. Iron regulatory protein 2 deficiency may correlate with insulin resistance. Biochem. Biophys. Res. Commun. 510, 191–197 (2019).
pubmed: 30685084
doi: 10.1016/j.bbrc.2019.01.022
pmcid: 30685084
Larrick, J. W. & Hyman, E. S. Acquired iron-deficiency anemia caused by an antibody against the transferrin receptor. N. Engl. J. Med. 311, 214–218 (1984).
pubmed: 6330553
doi: 10.1056/NEJM198407263110402
pmcid: 6330553
Hyman, E. S. Acquired iron-deficiency anaemia due to impaired iron transport. Lancet 1, 91–95 (1983).
pubmed: 6129457
doi: 10.1016/S0140-6736(83)91741-5
pmcid: 6129457
Rhodes, C. J. et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J. Am. Coll. Cardiol. 58, 300–309 (2011).
pubmed: 21737024
doi: 10.1016/j.jacc.2011.02.057
pmcid: 21737024
Ruiter, G. et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 37, 1386–1391 (2011).
pubmed: 20884742
doi: 10.1183/09031936.00100510
pmcid: 20884742
van Empel, V. P., Lee, J., Williams, T. J. & Kaye, D. M. Iron deficiency in patients with idiopathic pulmonary arterial hypertension. Heart Lung Circ. 23, 287–292 (2014).
pubmed: 24094431
doi: 10.1016/j.hlc.2013.08.007
pmcid: 24094431
von Haehling, S., Jankowska, E. A., van Veldhuisen, D. J., Ponikowski, P. & Anker, S. D. Iron deficiency and cardiovascular disease. Nat. Rev. Cardiol. 12, 659–669 (2015).
doi: 10.1038/nrcardio.2015.109
Visanji, N. P. et al. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson’s disease and multiple system atrophy. J. Parkinsons Dis. 3, 523–537 (2013).
pubmed: 24113558
doi: 10.3233/JPD-130197
pmcid: 24113558
Cotroneo, E. et al. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. Circ. Res. 116, 1680–1690 (2015).
pubmed: 25767292
doi: 10.1161/CIRCRESAHA.116.305265
pmcid: 25767292
Matak, P. et al. Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. Proc. Natl Acad. Sci. USA 113, 3428–3435 (2016).
pubmed: 26929359
doi: 10.1073/pnas.1519473113
pmcid: 26929359
Cooper, M. S., Stark, Z., Lunke, S., Zhao, T. & Amor, D. J. IREB2-associated neurodegeneration. Brain 142, e40 (2019).
pubmed: 31243445
doi: 10.1093/brain/awz183
pmcid: 31243445
Costain, G. et al. Absence of iron-responsive element-binding protein 2 causes a novel neurodegenerative syndrome. Brain 142, 1195–1202 (2019).
pubmed: 30915432
doi: 10.1093/brain/awz072
pmcid: 30915432
Galy, B., Ferring-Appel, D., Kaden, S., Grone, H. J. & Hentze, M. W. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab. 7, 79–85 (2008).
pubmed: 18177727
doi: 10.1016/j.cmet.2007.10.006
pmcid: 18177727
Neschen, S. et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl- CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2, 55–65 (2005).
pubmed: 16054099
doi: 10.1016/j.cmet.2005.06.006
pmcid: 16054099
Neschen, S. et al. n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator- activated receptor-alpha-dependent manner. Diabetes 56, 1034–1041 (2007).
pubmed: 17251275
doi: 10.2337/db06-1206
pmcid: 17251275
Hohmeier, H. E. et al. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel- dependent and -independent glucose-stimulated insulin secretion. Diabetes 49, 424–430 (2000).
pubmed: 10868964
doi: 10.2337/diabetes.49.3.424
pmcid: 10868964
Zimmer, M. et al. Small-molecule inhibitors of HIF-2a translation link its 5’UTR iron-responsive element to oxygen sensing. Mol. Cell 32, 838–848 (2008).
pubmed: 19111663
pmcid: 3978139
doi: 10.1016/j.molcel.2008.12.004
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
pubmed: 24157548
pmcid: 3969860
doi: 10.1038/nprot.2013.143
Guo, B., Yu, Y. & Leibold, E. A. Iron regulates cytoplasmic levels of a novel iron-responsive element- binding protein without aconitase activity. J. Biol. Chem. 269, 24252–24260 (1994).
pubmed: 7523370
pmcid: 7523370
Leibold, E. A. & Munro, H. N. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5’ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl Acad. Sci. USA 85, 2171–2175 (1988).
pubmed: 3127826
doi: 10.1073/pnas.85.7.2171
pmcid: 3127826
Beaumont, C., Torti, S. V., Torti, F. M. & Massover, W. H. Novel properties of L-type polypeptide subunits in mouse ferritin molecules. J. Biol. Chem. 271, 7923–7926 (1996).
pubmed: 8626471
doi: 10.1074/jbc.271.14.7923
pmcid: 8626471
Vendeix, F. A. et al. Human tRNA(Lys3)(UUU) is pre-structured by natural modifications for cognate and wobble codon binding through keto-enol tautomerism. J. Mol. Biol. 416, 467–485 (2012).
pubmed: 22227389
doi: 10.1016/j.jmb.2011.12.048
pmcid: 22227389